niacin has been researched along with Impaired Glucose Tolerance in 9 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to observe the antihypertensive effect of losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension (EH) combined with isolated impaired fasting glucose (i-IFG)." | 9.22 | Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose. ( Jiang, XS; Liu, L; Ning, N; Tan, MH; Wei, P; Xiao, WY; Yi, D; Zhou, L, 2016) |
| "The objective of this study was to observe the antihypertensive effect of losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension (EH) combined with isolated impaired fasting glucose (i-IFG)." | 5.22 | Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose. ( Jiang, XS; Liu, L; Ning, N; Tan, MH; Wei, P; Xiao, WY; Yi, D; Zhou, L, 2016) |
| "Ecological evidence suggests that niacin (nicotinamide and nicotinic acid) fortification may be involved in the increased prevalence of obesity and type 2 diabetes, both of which are associated with insulin resistance and epigenetic changes." | 3.79 | Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats. ( Cao, JM; Cao, Y; Gong, XJ; Guo, J; Guo, M; Li, D; Lun, YZ; Luo, N; Sun, WP; Tian, YJ; Zhou, SS, 2013) |
| "Niacin is an antidyslipidemic agent that may cause blood sugar elevation in patients with diabetes, but its effects on glucose and insulin values in nondiabetic statin-treated subjects with cardiovascular disease and at high risk for diabetes are less well known." | 2.82 | Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH. ( Bittner, VA; Boden, WE; Dunbar, RL; Fleg, JL; Goldberg, RB; Grunberger, G; Guyton, JR; Leiter, LA; McBride, R; Robinson, JG; Simmons, DL; Wysham, C; Xu, P, 2016) |
| "placebo on the incidence of new onset type 2 diabetes mellitus (T2DM) and cardiovascular event rates in patients with normal and impaired fasting glucose (IFG)." | 2.78 | Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. ( Canner, PL; Maccubbin, D; Sazonov, V; Sisk, CM, 2013) |
| "Patients with type 2 diabetes and hyperlipidemia were included for review if they received the combination of pioglitazone at doses ≥ 15 mg/day and extended-release niacin (Niaspan) at doses ≥ 1000 mg/day for ≥6 months." | 1.39 | The effect of pioglitazone and extended-release niacin on HDL-cholesterol in diabetes patients in a real-world setting. ( Bhargava, A; Gleason, S; Johnson, JF; Vaughan, AG; Yarlagadda, KV, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wierzbicki, AS | 1 |
| Sazonov, V | 1 |
| Maccubbin, D | 1 |
| Sisk, CM | 1 |
| Canner, PL | 1 |
| Li, D | 1 |
| Tian, YJ | 1 |
| Guo, J | 1 |
| Sun, WP | 1 |
| Lun, YZ | 1 |
| Guo, M | 1 |
| Luo, N | 1 |
| Cao, Y | 1 |
| Cao, JM | 1 |
| Gong, XJ | 1 |
| Zhou, SS | 1 |
| Bhargava, A | 1 |
| Gleason, S | 1 |
| Vaughan, AG | 1 |
| Johnson, JF | 1 |
| Yarlagadda, KV | 1 |
| Xiao, WY | 1 |
| Ning, N | 1 |
| Tan, MH | 1 |
| Jiang, XS | 1 |
| Zhou, L | 1 |
| Liu, L | 1 |
| Yi, D | 1 |
| Wei, P | 1 |
| Goldberg, RB | 1 |
| Bittner, VA | 1 |
| Dunbar, RL | 1 |
| Fleg, JL | 1 |
| Grunberger, G | 1 |
| Guyton, JR | 1 |
| Leiter, LA | 1 |
| McBride, R | 1 |
| Robinson, JG | 1 |
| Simmons, DL | 1 |
| Wysham, C | 1 |
| Xu, P | 1 |
| Boden, WE | 1 |
| Cooper-DeHoff, RM | 1 |
| Pacanowski, MA | 1 |
| Pepine, CJ | 1 |
| Asano, M | 1 |
| Yamada, N | 1 |
| Offermanns, S | 1 |
3 reviews available for niacin and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit | 2009 |
[Dyslipidemia management in patients with impaired glucose tolerance].
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol, HDL; Clofibric Acid; Eicosapen | 2005 |
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
Topics: Animals; Flushing; Glucose Intolerance; Humans; Hypolipidemic Agents; Insulin Resistance; Niacin; Re | 2006 |
3 trials available for niacin and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose.
Topics: Blood Glucose; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Meth | 2013 |
Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Essential Hypertension; F | 2016 |
Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.
Topics: Aged; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus; Drug Therapy, Combination; Ezet | 2016 |
3 other studies available for niacin and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Sugar, sugar.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucose Intolerance; Humans; Hypolipidemic Agents; | 2013 |
Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats.
Topics: Animals; Betaine; Choline; CpG Islands; Dietary Supplements; DNA; DNA Damage; DNA Methylation; Epige | 2013 |
The effect of pioglitazone and extended-release niacin on HDL-cholesterol in diabetes patients in a real-world setting.
Topics: Analysis of Variance; Cholesterol, HDL; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Drug | 2013 |